The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to ClinicVigneshwaran Namasivayam(University of Bonn), Siddappa N. Byrareddy(University of Nebraska Medical Center)Journal of Medicinal ChemistryDecember 5, 201810.1021/acs.jmedchem.8b00843Cited by 181SaveCiteExport RISWatch citationsRelated PapersDifferential immunometabolic responses to Delta and Omicron SARS-CoV-2 variants in golden syrian hamsters|iScience|2024|8